← Eichor
Condition: Malignant Brain Tumor Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Malignant Brain Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · 590 location(s) · SWOG Cancer Research Network · NCT03418961rTMS for Postoperative Brain Tumor Patients
NA · 1 location(s) · Brian J.Gill · NCT07530536Assessment of Tiredness During Awake Resection of Intracerebral Tumors
Phase N/A · 1 location(s) · Region Skane · NCT06922487Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05366179Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
EARLY_Phase 1 · 1 location(s) · Children's Hospital of Philadelphia · NCT05555550Neurocognition After Radiotherapy in CNS- and Skull-base Tumors
NA · 3 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05727605Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared
Phase 3 · 1 location(s) · Northwell Health · NCT05271240Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
Phase 3 · 4 location(s) · Mayo Clinic · NCT03750227Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
NA · 2 location(s) · Brigham and Women's Hospital · NCT040334975G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
Phase 1/Phase 2 · 3 location(s) · Institute of Cancer Research, United Kingdom · NCT0663026068Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
EARLY_Phase 1 · 1 location(s) · Peking Union Medical College Hospital · NCT05549024Intraoperative Fluorescence-Guided Aspirate Tissue Monitoring of 5-ALA During Brain Tumor Surgery
NA · 1 location(s) · University of Illinois at Chicago · NCT07111182Metabolic Characterization of Space Occupying Lesions of the Brain
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT04233788Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Ref
Phase 2 · 1 location(s) · Northwell Health · NCT02800486C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT04099797SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)
Phase N/A · 1 location(s) · Seoul National University Hospital · NCT05254197Low-grade Gliomas in Argentina: Incidence, Survival, and Therapeutic Strategies
Phase N/A · 6 location(s) · Hospital Italiano de Buenos Aires · NCT076313385G-PEARL: Paxalisib in Malignant Brain Tumours
Phase 1/Phase 2 · 1 location(s) · Institute of Cancer Research, United Kingdom · NCT07391215Brain Connectivity Changes in Glioma Patients During Treatment
Phase N/A · 1 location(s) · Johannes Kepler University of Linz · NCT07612917Mapping of Human Cognition
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT05989893Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline
Phase N/A · 1 location(s) · Tata Memorial Centre · NCT06779487Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries
Phase N/A · 1 location(s) · Umeå University · NCT05819008The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies
Phase 3 · 1 location(s) · Stephen Lownie · NCT06229483Evaluation of the CONVIVO System
NA · 1 location(s) · Dartmouth-Hitchcock Medical Center · NCT05139277Remote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cran
Phase 2 · 1 location(s) · Mayo Clinic · NCT06377696Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors
Phase 2 · 1 location(s) · Samsung Medical Center · NCT07688356Development of MRF for Characterization of Brain Tumors After Radiotherapy
NA · 2 location(s) · Case Comprehensive Cancer Center · NCT06101069APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Phase 2 · 35 location(s) · Apollomics Inc. · NCT03175224Intravital Microscopy in Human Solid Tumors
NA · 1 location(s) · Mayo Clinic · NCT03823144Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
NA · 1 location(s) · Medical University of Vienna · NCT06512311
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.